Sanofi Consumer Healthcare India Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India's promoters – Opella Healthcare Participations B.V. and promoter group member Opal Bidco SAS – have filed a routine compliance declaration with the stock exchanges dated 5 January 2026. Under SEBI's Regulation 31(4), both entities confirmed that they, along with persons acting in concert, have not created any encumbrance (such as a pledge or lien) on the equity shares they hold in the company as of 31 December 2025. The declaration extends up to the date of the filing. This is a standard yearly disclosure required from promoters and is not triggered by any specific transaction.
This is a routine regulatory filing with no impact on share price or shareholder value. It simply confirms that the promoter group has not pledged or encumbered any of their holdings, which is generally seen as a neutral-to-positive sign of stability.